Advertisement
Global  

“News neutrality by unbiased coverage”
One News Page
> >

Biofrontera to Present at the 4th Annual Dawson James Small Cap Growth Stock Conference

GlobeNewswire Monday, 15 October 2018
Leverkusen, Germany, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F), an international biopharmaceutical company, today announced that Dr. Hermann Lübbert, Biofrontera’s Chief Executive Officer, is scheduled to present at the 4^th Annual Dawson James Small Cap Growth Stock Conference, being held on October 29-30, 2018 at Wyndham Grand Hotel in Jupiter, FL.Details of the presentation are below:

*Event:* 4^th Annual Dawson James Small Cap Growth Stock Conference

*Date:* Tuesday, October 30, 2018

*Time:* 11:00am ET

*Location:* Track 1 - Preserve Ballroom C

Biofrontera’s management team will also be available for one-on-one meetings with investors who are registered to attend the event. Alternatively, interested investors may contact Tram Bui of The Ruth Group at tbui@theruthgroup.com or (646) 536-7035 to schedule a meeting.

*-End-*

*About Biofrontera:*Biofrontera AG is an international biopharmaceutical company specializing in the development and commercialization of a platform of pharmaceutical products for the treatment of dermatological conditions and diseases caused primarily by exposure to sunlight that results in sun damage to the skin. Biofrontera's approved products focus on the treatment in the U.S. and Europe of actinic keratoses, which are skin lesions that can sometimes lead to skin cancer, as well as the treatment of certain forms of basal cell carcinoma in the European Union. American Depositary Shares representing Biofrontera's ordinary shares are listed on the NASDAQ Capital Market under the symbol "BFRA", and Biofrontera's ordinary shares are listed in the Frankfurt Stock Exchange (B8F, ISIN: DE0006046113). Information is also available at www.biofrontera.com.

*Forward Looking Statements:*

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995 regarding the public offering and the intended use of proceeds from the offering. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimate" and "intend," among others. Such forward-looking statements are based on the currently held beliefs and assumptions of the management of Biofrontera AG, which are expressed in good faith and, in their opinion, reasonable. Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, financial condition, performance, or achievements of the Company, or industry results, to differ materially from the results, financial condition, performance or achievements expressed or implied by such forward-looking statements. These risks, uncertainties and other factors are set forth in the Registration Statement on Form F-1 filed with the SEC, including in the section "Risk Factors," and in future reports filed with the SEC. Given these risks, uncertainties and other factors, prospective investors are cautioned not to place undue reliance on these forward-looking statements. The Company does not undertake an obligation to update or revise any forward-looking statement.

CONTACT: Enquiries, please contact:
Biofrontera AG
Thomas Schaffer, Chief Financial Officer
+49 (0) 214 87 63 2 0
ir@biofrontera.com

IR UK: Seton Services
Toni Vallen +44(0) 20 7729 0805

IR and PR US: The Ruth Group
IR: Tram Bui +1 646-536-7035
PR: Kirsten Thomas +1 508-280-6592
0
shares
ShareTweetSavePostSend
 

Recent related news from verified sources

MSCI November Semi-Annual Index Review Announcement Scheduled for November 13, 2018

NEW YORK--(BUSINESS WIRE)--MSCI Inc. (NYSE:MSCI), a leading provider of research-based indexes and analytics, will announce the results of the November 2018...
Business Wire - Press Releases

Interpace Diagnostics to Participate in 9th Annual Craig-Hallum Alpha Select Conference

*PARSIPPANY, NJ, Nov. 09, 2018 (GLOBE NEWSWIRE) -- *Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that the Company has been invited to...
GlobeNewswire - Press Releases

Emphasis on unity at Allegheny Conference annual meeting

The late Fred Rogers opened the 2018 annual meeting of the Allegheny Conference on Community Development Thursday night, and on a small screen on the stage of a...
bizjournals - Business

A.M. BestTV at SIRC: Regulatory Changes and Growth Set to Boost Reinsurers’ Share of Asia Risk

A.M. BestTV at SIRC: Regulatory Changes and Growth Set to Boost Reinsurers’ Share of Asia Risk
OLDWICK, N.J.--(BUSINESS WIRE)--In this episode of A.M.BestTV, attendees at the annual Singapore International Reinsurance Conference (SIRC) said market growth,...
Business Wire - Press Releases

You Might Like


Tweets about this


Other recent news in Press Releases

Pressure BioSciences, Inc. Reports Third Quarter and YTD 2018 Financial Results and Provides Business UPDATEInfineon enables open source SOFTWARE stack for TPM 2.0 -- for easier integration of security into industrial and automotive applications
Celebrate the Festival of Lights with CALIFORNIA WalnutsAIDUS Project, a global funds market platform, successful meet-up in HONG KONG
Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2018 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Contact us  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest